Investigational drug · Phase 2
TQD3524
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia.
Phase 2Last checked: Nov 19, 2026Latest source record: Sep 4, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "TQD3524"
First trial start
2026
Jul 21, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "TQD3524", any sponsor or status.
Conditions studied
As listed on its trial records.
- Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia
Approved drugs for the same conditions: Pneumonia · Infectious disease and vaccines
Largest trials
Live from ClinicalTrials.gov: studies naming "TQD3524" as an intervention, largest first.
- To Evaluate the Pharmacokinetics and Safety of TQD3524 for Injection in Renal Impairment SubjectsCompleted
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
NCT06522945 · 48 participants · Start Jul 24, 2024 · Primary completion Dec 18, 2025
Drug: TQD3524; TQD3524 and 4 more · For: Multi-resistant Gram-negative Bacteria Cause Infection
Sites: Jinan, China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
NCT07512596 · 48 participants (planned) · Start Jul 21, 2026 · Primary completion Jul 2027
Drug: TQD3524; Meropenem for injection and 1 more · For: Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia
Sites: Bengbu, China; Beijing, China; Chongqing, China · 27 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.